Skip to main content

Table 1 Characteristics of the study population

From: Craniofacial and dentoalveolar morphology in individuals with Prader–Willi syndrome: a case-control study

  PWS
< 12 years (n = 12)
PWS
12–20 years (n = 10)
PWS
> 20 years (n = 20)
Control
< 12 years (n = 66)
Control
12–20 years (n = 69)
Control
> 20 years (n = 54)
Age, mean years (SD) 8.8 (± 2.1) 15.9 (± 2.3) 26.9 (± 6.8) 8.0 (± 1.4) 13.5 (± 2.0) 33.3 (± 1.5)
No. of males/females 5/7 6/4 11/9 19/47 15/54 16/38
Medication
 No. of GH users 11 9 17 0 0 0
 GH treatment duration, mean months (SD) 56.2 (± 21.8) 114.7 (± 51.3) 67.1 (± 54.0)